A comprehensive study of iRGD-modified liposomes with improved chemotherapeutic efficacy on B16 melanoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A comprehensive study of iRGD-modified liposomes with improved chemotherapeutic efficacy on B16 melanoma
Authors
Keywords
-
Journal
DRUG DELIVERY
Volume 22, Issue 1, Pages 10-20
Publisher
Informa UK Limited
Online
2014-04-15
DOI
10.3109/10717544.2014.903580
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Improvement of pharmacokinetic and antitumor activity of PEGylated liposomal doxorubicin by targeting with N-methylated cyclic RGD peptide in mice bearing C-26 colon carcinomas
- (2013) Mohamadreza Amin et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Somatostatin receptor-mediated tumor-targeting drug delivery using octreotide-PEG-deoxycholic acid conjugate-modified N-deoxycholic acid-O, N-hydroxyethylation chitosan micelles
- (2012) Meirong Huo et al. BIOMATERIALS
- Transferrin-Conjugated Micelles: Enhanced Accumulation and Antitumor Effect for Transferrin-Receptor-Overexpressing Cancer Models
- (2012) Jun Yue et al. MOLECULAR PHARMACEUTICS
- The effect of hydrophilic chain length and iRGD on drug delivery from poly(ε-caprolactone)-poly(N-vinylpyrrolidone) nanoparticles
- (2011) Zhenshu Zhu et al. BIOMATERIALS
- Binding and transport of PAMAM-RGD in a tumor spheroid model: The effect of RGD targeting ligand density
- (2011) Carolyn L. Waite et al. BIOTECHNOLOGY AND BIOENGINEERING
- Liposomal drug formulations in cancer therapy: 15 years along the road
- (2011) Marije Slingerland et al. DRUG DISCOVERY TODAY
- APN/CD13-targeting as a strategy to alter the tumor accumulation of liposomes
- (2011) Michael Dunne et al. JOURNAL OF CONTROLLED RELEASE
- Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes
- (2011) Yu Xiang et al. JOURNAL OF CONTROLLED RELEASE
- Targeted delivery of a combination therapy consisting of combretastatin A4 and low-dose doxorubicin against tumor neovasculature
- (2011) Tingyuan Yang et al. Nanomedicine-Nanotechnology Biology and Medicine
- How Stealthy are PEG-PLA Nanoparticles? An NIR In Vivo Study Combined with Detailed Size Measurements
- (2011) Andreas Schädlich et al. PHARMACEUTICAL RESEARCH
- Ursolic acid induces HL60 monocytic differentiation and upregulates C/EBPβ expression by ERK pathway activation
- (2010) Ting Zhang et al. ANTI-CANCER DRUGS
- Synthesis and evaluation of new iRGD peptide analogs for tumor optical imaging
- (2010) Yunpeng Ye et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs
- (2010) K. N. Sugahara et al. SCIENCE
- Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
- (2009) Kazuki N. Sugahara et al. CANCER CELL
- Rapamycin inhibits lung metastasis of B16 melanoma cells through down-regulating alphav integrin expression and up-regulating apoptosis signaling
- (2009) Zhuoshun Yang et al. CANCER SCIENCE
- Neuropilins in Tumor Biology
- (2009) A. Bagri et al. CLINICAL CANCER RESEARCH
- NGR-modified micelles enhance their interaction with CD13-overexpressing tumor and endothelial cells
- (2009) Xun Wang et al. JOURNAL OF CONTROLLED RELEASE
- Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis
- (2008) Elena Geretti et al. ANGIOGENESIS
- Neuropilins: structure, function and role in disease
- (2008) Caroline Pellet-Many et al. BIOCHEMICAL JOURNAL
- Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers
- (2008) F. Gu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search